Genetron Health Announces Completion of Going Private Transaction
March 28, 2024 13:30 ET
|
Genetron Holdings Limited
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Shareholders’ Approval of Merger Agreement
February 21, 2024 06:00 ET
|
Genetron Holdings Limited
BEIJING, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Hold Extraordinary General Meeting of Shareholders
January 17, 2024 06:05 ET
|
Genetron Holdings Limited
BEIJING, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction
October 11, 2023 16:30 ET
|
Genetron Holdings Limited
BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Receipt of Notification from Nasdaq
May 23, 2023 16:30 ET
|
Genetron Holdings Limited
BEIJING, May 23, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Regains Compliance With Nasdaq Minimum Bid Price Requirement
January 18, 2023 07:00 ET
|
Genetron Holdings Limited
BEIJING, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Receipt of Notification from Nasdaq
November 07, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Reports Unaudited Second Quarter 2022 Financial Results
October 12, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
September 02, 2022 07:00 ET
|
Genetron Holdings Limited
BEIJING, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
August 22, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...